Usually the waiting game is the game of losers in subpenny land. It's so easy to get left holding the bag when waiting too long. I've watched it happen to so many stocks where people were waiting on that "assay" or the "report" on barrels/day and the all too famous "FDA approval". In this case we already know what's happening. The company is MAKING money. We know how much just not exactly in detail.
Many penny stocks are hanging around .05-.10 on negative earnings. Does it deserve to trade for more than this company with forecasts of about .018-.02/share in EBITDA earnings?
Sometimes the market takes it time bringing stocks up to value.
What I'm waiting for are next quarter's earnings. They should be pretty awesome and the best of all the company's history. They should show lower debt with all this BMAK selling and higher cash flows.
Today is the last day trading of Q2. Starting next week the accountant gets to work on what happened and what exactly BMAK was doing all this time. I have a feeling there might also be an 8-k adding recent events to the next quarter filing when the acquisition closes in the next month or so. Waiting sucks but the way this company is growing it would be so crappy to bail right before the climb upwards. Good luck!
News 
Market Data 
Discover 
